Terumo Aortic announces first commercial implants of RelayPro endovascular device in the USA

Following the recent approval by the US Food and Drug Administration (FDA) of the RelayPro thoracic stent graft system for the treatment of patients with fusiform and saccular aneurysms, and penetrating atherosclerotic ulcers (PAUs) in the descending thoracic aorta, Terumo Aortic has announced the first commercial implants of this device in the USA. The implants […]

The post Terumo Aortic announces first commercial implants of RelayPro endovascular device in the USA appeared first on Vascular News.